Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

505
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
505
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

388
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
388
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

268
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
268
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

708
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
708
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

318
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
318
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

528
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
528

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac fibrosis induced by high-fat diet in ApoE-deficient male mice is exacerbated by genetic deletion of PACAP-PAC1 signaling.

Journal of neuroendocrinology·2025
Same author

[2019 ESC guidelines: consensus in Europe for 25 years].

Herz·2019
Same author

[The 4 R of the ESC guidelines 2018: relevance, redundancy, reality, and relativization].

Herz·2018
Same author

[Management of pericarditis and pericardial effusion, constrictive and effusive-constrictive pericarditis].

Herz·2018
Same author

Heart failure 2.0 or 0.1?

Herz·2018
Same author

Treatment options in myocarditis and inflammatory cardiomyopathy : Focus on i. v. immunoglobulins.

Herz·2018

Related Experiment Video

Updated: Mar 3, 2026

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

3.2K

[Inflammatory cardiomyopathy and myocarditis].

B Maisch1,2, A D Ristic3, S Pankuweit4,5

  • 1Fachbereich Medizin, Philipps-Universität Marburg, privat: Feldbergstr. 45, 35043, Marburg, Deutschland. bermaisch@gmail.com.

Herz
|April 29, 2017
PubMed
Summary

Diagnosing inflammatory cardiomyopathy and myocarditis involves assessing the cause and clinical presentation. Differentiating viral from autoreactive forms via biopsy enables targeted therapy beyond standard heart failure treatment.

Keywords:
CardiomyopathiesEchocardiographyEndomyocardial biopsyMyocarditisPericarditis

More Related Videos

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

10.5K
Isolation and Identification of Extravascular Immune Cells of the Heart
08:24

Isolation and Identification of Extravascular Immune Cells of the Heart

Published on: August 23, 2018

14.1K

Related Experiment Videos

Last Updated: Mar 3, 2026

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

3.2K
Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

10.5K
Isolation and Identification of Extravascular Immune Cells of the Heart
08:24

Isolation and Identification of Extravascular Immune Cells of the Heart

Published on: August 23, 2018

14.1K

Area of Science:

  • Cardiology
  • Pathology
  • Medical Imaging

Background:

  • Inflammatory cardiomyopathy and myocarditis require precise diagnosis and etiology assessment.
  • European Society of Cardiology guidelines provide a framework for management.
  • Recent advancements offer new diagnostic and therapeutic strategies.

Purpose of the Study:

  • To outline diagnostic and treatment approaches for inflammatory cardiomyopathy and myocarditis.
  • To integrate etiological considerations into patient management.
  • To highlight recent developments in the field based on ESC guidelines.

Main Methods:

  • Review of a landmark position paper from the European Society of Cardiology's Working Group Myocardial and Pericardial Diseases.
  • Incorporation of recent developments in diagnosis and treatment.
  • Discussion of multimodality imaging and invasive diagnostic procedures.
  • Histological and molecular analysis of endomyocardial biopsies.

Main Results:

  • Diagnosis hinges on assessing etiology, clinical presentation, course, and prognosis.
  • Endomyocardial biopsy with histological and molecular methods distinguishes viral from autoreactive myocarditis.
  • This differentiation allows for individualized, targeted therapy.

Conclusions:

  • Accurate etiological diagnosis is crucial for managing inflammatory cardiomyopathy and myocarditis.
  • Distinguishing between viral and autoreactive forms guides personalized treatment strategies.
  • Targeted therapies, informed by biopsy results, offer benefits beyond general heart failure management.